Latest News of PBM
PhRMA shells out to get PBM reform over finish line
By POLITICO |
1 week ago
PhRMA launches a seven-figure ad blitz to push for a crackdown on pharmaceutical middlemen, focusing on saving benefits for patients. The push is part of a final sprint to pass PBM reforms in the lame...
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
By Forbes |
1 week ago
In the United States, patients are now able to choose lower-priced biosimilars for Humira, an autoimmune disease treatment, due to rebating practices by drug manufacturers and pharmacy benefit manager...
PBM vibe check
By POLITICO |
1 month ago
Legislation targeting pharmacy benefit managers (PBMs) may be included in upcoming legislative packages, pending control of the White House and Congress. Congress debates reforming PBMs to improve dru...
-
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
By Yahoo! Finance | 1 month agoThe Federal Trade Commission filed a lawsuit against the top three PBMs, alleging that they manipulated drug prices to inflate rebates, impacting patients. CVS, Cigna, and UnitedHealth Group stocks fe...
-
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans' Healthcare
By Forbes | 3 months agoThe focus is on pharmacy benefit managers (PBMs) facing scrutiny for their role in rising drug costs, anti-competitive practices, and price-fixing. PBMs' opaque operations impact drug availability, co...
-
Untangling The $500 Billion PBM Web: The Opaque Relationship Between Employers And Drug Middlemen
By Forbes | 3 months agoThe FTC's probe into pharmacy benefit managers for anti-competitive practices has sparked legal actions from state Attorneys General. While PBMs claim to control costs, investigations reveal they stee...
-
PBM hearing puts drug pricing in focus
By Yahoo! Finance | 4 months agoPBM executives are discussing ways to reduce prescription drug prices before Congress. Questions focus on pricing, rebates, and the intermediary role between pharmacies and drug manufacturers. Yahoo F...
-
PBM execs face House grilling
By The Hill | 4 months agoExecutives from major PBMs will testify before the House Oversight Committee on the impact of PBMs on prescription drug costs. Bipartisan pressure is mounting for reforms due to concerns over pricing ...
-
PBM report spurs calls for congressional action
By The Hill | 4 months agoThe FTC report highlights concerns about PBMs' influence on drug costs and access, leading lawmakers to push for reform. Bipartisan efforts aim to address PBM practices, with ongoing scrutiny on their...
-
FTC Chair Khan slams PBMs for higher drug prices in an interim report on the industry
By Yahoo! Finance | 4 months agoThe FTC's report blames top PBMs for high drug prices due to consolidation and market dominance. The "Big Three" PBMs control 80% of US prescriptions, with revenues rising to over $1 trillion. Smaller...
-
Community pharmacists join the PBM ad frenzy
By POLITICO | 5 months agoIndependent pharmacists are launching a campaign to urge Congress to regulate pharmacy benefit managers. With digital, TV, and print ads, they aim to expose PBMs and reduce drug costs. The lobbying ef...